Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Lucid Diagnostics Q2 2024 Adj EPS $(0.20) Beats $(0.22) Estimate, Sales $976.00K Miss $1.23M Estimate

Author: Benzinga Newsdesk | August 12, 2024 08:08am
Lucid Diagnostics (NASDAQ:LUCD) reported quarterly losses of $(0.20) per share which beat the analyst consensus estimate of $(0.22) by 9.09 percent. This is a 13.04 percent increase over losses of $(0.23) per share from the same period last year. The company reported quarterly sales of $976.00 thousand which missed the analyst consensus estimate of $1.23 million by 20.43 percent. This is a 513.84 percent increase over sales of $159.00 thousand the same period last year.

Posted In: LUCD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist